While 6 medical device companies and 11 pharmaceutical organizations made the cut for this year’s Fortune 500 list, Quintiles (#476) was the only contract research organization (CRO) to make an appearance. With over $4 billion in revenue in 2014, this is Quintiles’ second year on the list.
To see which pharma and biotech companies made the list, click here.
To see which medical device companies made the list, click here.
To see this year’s Fortune 500 ranking in its entirety, click here.